AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100. A total of 61 filers reported holding AVROBIO INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $734,000 | +142.2% | 36,483 | +95.7% | 0.09% | +309.5% |
Q2 2019 | $303,000 | -63.8% | 18,644 | -50.9% | 0.02% | -46.2% |
Q1 2019 | $837,000 | +152.9% | 38,000 | +91.0% | 0.04% | +69.6% |
Q4 2018 | $331,000 | -34.8% | 19,900 | +103.1% | 0.02% | -20.7% |
Q3 2018 | $508,000 | – | 9,800 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SV Health Investors, LLC | 2,736,027 | $45,555,000 | 28.05% |
Aisling Capital Management LP | 736,998 | $12,271,000 | 12.93% |
Cormorant Asset Management, LP | 1,357,784 | $22,607,000 | 1.84% |
New Leaf Venture Partners, L.L.C. | 215,550 | $3,589,000 | 0.98% |
Eventide Asset Management | 928,891 | $14,901,000 | 0.66% |
EMERALD ADVISERS, LLC | 380,636 | $6,338,000 | 0.31% |
EMERALD MUTUAL FUND ADVISERS TRUST | 372,865 | $6,208,000 | 0.29% |
Blackstone Inc. | 2,962,325 | $49,323,000 | 0.28% |
PFM Health Sciences, LP | 241,413 | $4,020,000 | 0.11% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 143,762 | $2,394,000 | 0.10% |